Could GLP-1 medications be reducing the economic penalty for women?
New research explores how weight-loss drugs like GLP-1s might influence social and professional outcomes. This video examines findings regarding shifts in marriage and employment rates among women following significant weight changes.
Economist Rebecca Diamond, a Martin Feldstein Professor of Economics, analyzed data from the Understanding America Study to investigate the social and financial costs women face due to body size. Her research, published by the National Bureau of Economic Research, suggests that first impressions play a significant role in the 'female obesity penalty.'
Comparing women using GLP-1s to a control group, Diamond found that after 1.5 years of use, single women saw their chances of marriage or moving in with a partner rise by as much as 28.6 percentage points. Additionally, the likelihood of unemployed women securing a job increased by 26.9 percentage points. While these shifts are striking, Diamond notes the need to consider whether these changes stem from reduced bias or if other factors, such as improved mood or motivation, are at play.
Source: Are GLP-1 meds really helping unemployed women find work?
